Tag: NASDAQ: AMRN

Business

Amarin Corp PLC (NASDAQ: AMRN) Drops 5% After Supreme Court Rejects its Vascepa Patents Appeal

Amarin Corp PLC (NASDAQ: AMRN) dropped 5.24% after the Supreme Court rejected efforts by its subsidiary to revive Vascepa patents in a legal suit against drug makers Dr. Reddy’s Laboratories Ltd. and Hikma Pharmaceuticals PLC. Supreme Court declines to hear Amarin’s patent appeal Supreme Court justices turned down Amarin Pharma’s […]